AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 282: H363-H371, 2002. First published September 27, 2001; doi:10.1152/ajpheart.00319.2001
0363-6135/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/1/H363    most recent
00319.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qin, F.
Right arrow Articles by Liang, C.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qin, F.
Right arrow Articles by Liang, C.-S.
Vol. 282, Issue 1, H363-H371, January 2002

Loss of cardiac sympathetic neurotransmitters in heart failure and NE infusion is associated with reduced NGF

Fuzhong Qin, Raju S. Vulapalli, Suzanne Y. Stevens, and Chang-Seng Liang

Departments of Medicine and Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, New York 14642

Sympathetic neurotransmitters are diminished in cardiac efferent nerve endings in congestive heart failure (CHF). Similar changes occur after exogenous norepinephrine (NE) infusion. Since NE reduces nerve growth factor (NGF) in cultured cardiomyocytes, we proposed to determine whether the loss of noradrenergic transmitters in the failing heart is caused by the NE-mediated reduction of NGF or its neurotrophic receptor tyrosine kinase A (TrKA). Dogs were assigned to receive either rapid ventricular pacing (225 beats/min) or NE infusion (0.5 µg/kg/min) for 8 wk. Control animals received either cardiac pacing of 100 beats/min or saline infusion. We measured NGF and TrKA proteins by Western blot and immunocytochemistry and measured NGF and TrKA mRNAs by reverse transcription polymerase chain reaction, neuronal catecholaminergic histofluorescence, tyrosine hydroxylase-immunostained profiles, and plasma NE. Rapid ventricular pacing produced CHF with increased plasma NE, decreased myocardial NGF protein (0.61 ± 0.07 vs. 1.04 ± 0.04, P < 0.05), TrKA protein (0.75 ± 0.08 vs. 0.98 ± 0.06, P < 0.05), NGF and TrKA mRNAs and reduced catecholaminergic histofluorescence (197 ± 23 vs. 485 ± 43, P < 0.05), and tyrosine hydroxylase profiles (360 ± 51 vs. 773 ± 36, P < 0.05). Decreases in tissue NGF and TrKA protein were also noted by immunocytochemistry. Similar changes occurred in NE-treated animals. Tissue NGF and TrKA levels correlated closely with the noradrenergic transmitter profiles. We conclude that cardiac NGF and TrKA are reduced by rapid ventricular pacing and NE infusion, and that these changes correlate with decreases of cardiac catecholaminergic and tyrosine hydroxylase profiles. Findings indicate that decrease of cardiac sympathetic transmitters in heart failure is associated with NE-mediated reduction of NGF and TrKA.

nerve growth factor; norepinephrine; sympathetic efferent nerve fibers


This article has been cited by other articles:


Home page
 J. Neurophysiol.Home page
J. A. Luther and S. J. Birren
Nerve Growth Factor Decreases Potassium Currents and Alters Repetitive Firing in Rat Sympathetic Neurons
J Neurophysiol, August 1, 2006; 96(2): 946 - 958.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs
Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts
Hypertension, February 1, 2006; 47(2): 209 - 215.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Esler and D. Kaye
Sympathetic Nervous System Neuroplasticity
Hypertension, February 1, 2006; 47(2): 143 - 144.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kiriazis, X.-J. Du, X. Feng, E. Hotchkin, T. Marshall, S. Finch, X.-M. Gao, G. Lambert, J. K. Choate, and D. M. Kaye
Preserved left ventricular structure and function in mice with cardiac sympathetic hyperinnervation
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1359 - H1365.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Cardinal, G. Rousseau, C. Bouchard, M. Vermeulen, J.-G. Latour, and P. L. Page
Myocardial electrical alteration in canine preparations with combined chronic rapid pacing and progressive coronary artery occlusion
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1496 - H1506.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. M. Canty Jr and J. A. Fallavollita
Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye
Circ. Res., October 31, 2003; 93(9): 796 - 798.
[Full Text] [PDF]

Home page
 JNMHome page
K. Mardon, O. Montagne, N. Elbaz, Z. Malek, A. Syrota, J.-L. Dubois-Rande, M. Meignan, and P. Merlet
Uptake-1 Carrier Downregulates in Parallel with the {beta}-Adrenergic Receptor Desensitization in Rat Hearts Chronically Exposed to High Levels of Circulating Norepinephrine: Implications for Cardiac Neuroimaging in Human Cardiomyopathies
J. Nucl. Med., September 1, 2003; 44(9): 1459 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. Morita, Y. Kuge, and N. Tamaki
What Is the Clinical Role of Neuronal Imaging?
J. Nucl. Med., September 1, 2003; 44(9): 1467 - 1468.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online